featured-image

tolgart Jaguar Health ( NASDAQ: JAGX ) shares continued to decline in the morning hours Thursday as the developer of plant-based drugs began trading on a split-adjusted basis following a 1-for-60 reverse stock split. Per the terms, every 60 shares of Jaguar ( JAGX ) common stock were automatically converted into one share of its common stock as the reverse stock split went into effect. The San Francisco, California-headquartered pharmaceutical company announced the reverse stock split last week, saying the corporate action was aimed at supporting compliance with Nasdaq's listing standards and attracting institutional investors.

The company's board has concluded that, besides supporting Nasdaq requirements, a reverse stock split will "provide Jaguar with the opportunity to achieve a share price and outstanding share count that is more attractive to institutional investors," CEO Lisa Conte added. More on Jaguar Health Jaguar Health, Inc. (JAGX) Q1 2024 Earnings Call Transcript Jaguar Health, Inc.



(JAGX) Q4 2023 Earnings Call Transcript Jaguar stock rallies 54% on licensing deal for chemo support drug Jaguar Health shareholders approve reverse stock split Seeking Alpha’s Quant Rating on Jaguar Health.

Back to Health Page